Baker Bros. Advisors LP 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-24 1:43 pm Purchase |
2023-11-21 | 13D | Bellicum Pharmaceuticals, Inc. BLCM |
Baker Bros. Advisors LP | 2,365,472 19.990% |
167,553 (+7.62%) |
Filing |
| 2023-05-05 4:24 pm Purchase |
2023-05-05 | 13D | Bellicum Pharmaceuticals, Inc. BLCM |
Baker Bros. Advisors LP | 2,197,919 19.990% |
2,197,919 (New Position) |
Filing |